Xilio Therapeutics Announces Upcoming Presentations at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting - Xilio Therapeutics (NASDAQ:XLO)
WALTHAM, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (NASDAQ:XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living
United States San Diego Melissa Forst Julissa Viana Linkedin Xilio Therapeutics Inc Exchange Commission
Source: benzinga.com